- Home
- RLMD vs CSCI Comparison
RLMD vs CSCI Comparison
Compare RLMD & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- CSCI
- Stock Information
- Founded
- RLMD 2004
- CSCI 1990
- Country
- RLMD United States
- CSCI Canada
- Employees
- RLMD N/A
- CSCI N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- CSCI
- Sector
- RLMD Health Care
- CSCI
- Exchange
- RLMD Nasdaq
- CSCI NYSE
- Market Cap
- RLMD 11.5M
- CSCI 9.9M
- IPO Year
- RLMD N/A
- CSCI 1996
- Fundamental
- Price
- RLMD $0.40
- CSCI $3.34
- Analyst Decision
- RLMD Hold
- CSCI
- Analyst Count
- RLMD 4
- CSCI 0
- Target Price
- RLMD $4.25
- CSCI N/A
- AVG Volume (30 Days)
- RLMD 4.5M
- CSCI 4.3K
- Earning Date
- RLMD 05-12-2025
- CSCI 05-13-2025
- Dividend Yield
- RLMD N/A
- CSCI N/A
- EPS Growth
- RLMD N/A
- CSCI N/A
- EPS
- RLMD N/A
- CSCI N/A
- Revenue
- RLMD N/A
- CSCI $9,030,000.00
- Revenue This Year
- RLMD N/A
- CSCI N/A
- Revenue Next Year
- RLMD N/A
- CSCI N/A
- P/E Ratio
- RLMD N/A
- CSCI N/A
- Revenue Growth
- RLMD N/A
- CSCI 127.46
- 52 Week Low
- RLMD $0.24
- CSCI $1.96
- 52 Week High
- RLMD $4.47
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- RLMD 51.73
- CSCI N/A
- Support Level
- RLMD $0.36
- CSCI N/A
- Resistance Level
- RLMD $0.44
- CSCI N/A
- Average True Range (ATR)
- RLMD 0.08
- CSCI 0.00
- MACD
- RLMD -0.00
- CSCI 0.00
- Stochastic Oscillator
- RLMD 26.98
- CSCI 0.00
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.